WealthTrust Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
WealthTrust Asset Management's PFE Position: Q1 2023 in Review
WealthTrust Asset Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 37,479 shares — an estimated $1.92M sold.
WealthTrust Asset Management first reported a position in PFE in Q3 2022 and held it in 2 quarters. The position peaked at $1.92M in Q4 2022. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.
- WealthTrust Asset Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
- WealthTrust Asset Management sold 37,479 Pfizer shares in Q1 2023, an estimated $1.92M.
- WealthTrust Asset Management first reported a position in Pfizer in Q3 2022 and held it in 2 quarters.
- WealthTrust Asset Management's Pfizer position peaked at $1.92M in Q4 2022.
- 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.
Based on WealthTrust Asset Management's 13F filing for Q1 2023, filed 28 Apr 2023.